Bahl & Gaynor’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
Bahl & Gaynor's CAH Position: Q2 2026 in Review
Bahl & Gaynor reduced its Cardinal Health (CAH) stake by 0.28% in Q2 2026, selling an estimated $3.53K and leaving 6,132 shares worth $1.46M. The position accounts for 0.01% of the portfolio, ranked #229.
Bahl & Gaynor first reported a position in CAH in Q1 2015 and has held it in 21 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Bahl & Gaynor held 6,132 shares of Cardinal Health worth $1.46M as of Q2 2026.
- Bahl & Gaynor sold 17 Cardinal Health shares in Q2 2026, an estimated $3.53K.
- Cardinal Health made up 0.01% of Bahl & Gaynor's portfolio in Q2 2026, its #229 holding.
- Bahl & Gaynor first reported a position in Cardinal Health in Q1 2015 and has held it in 21 quarters since.
- 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Bahl & Gaynor's 13F filing for Q2 2026, filed 13 Aug 2026.